Cargando…

TP53 Pro72 Allele Is Enriched in Oral Tongue Cancer and Frequently Mutated in Esophageal Cancer in India

PURPOSE: The tumor suppressor p53 is known to be inactivated frequently in various cancers. In addition, germline polymorphisms in TP53 are known to affect protein function and influence risk of developing different types of cancers. In this study, we analyzed the association of TP53 Pro72Arg polymo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adduri, Raju S. R., Katamoni, Rajender, Pandilla, Ramaswamy, Madana, Sandeep N., Paripati, Arun Kumar, Kotapalli, Viswakalyan, Bashyam, Murali Dharan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250174/ https://www.ncbi.nlm.nih.gov/pubmed/25436609 http://dx.doi.org/10.1371/journal.pone.0114002

Ejemplares similares

P53 nuclear stabilization is associated with FHIT loss and younger age of onset in squamous cell carcinoma of oral tongue
por: Adduri, Raju SR, et al.
Publicado: (2014)

Potentially important miRNAs in enteropathy-associated T-cell lymphoma pathogenesis: A pilot study
por: Clarke, Lindsey, et al.
Publicado: (2018)

Assessing the evolution of SARS-CoV-2 lineages and the dynamic associations between nucleotide variations
por: Gupta, Asmita, et al.
Publicado: (2023)

Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer
por: Desai, Sanket, et al.
Publicado: (2022)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients
por: Toyama, Tatsuya, et al.
Publicado: (2007)

Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis
por: Gonçalves, Meire Luzia, et al.
Publicado: (2014)

The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients
por: BABAEI, Farhad, et al.
Publicado: (2014)

Allelic Frequency of p53 Gene Codon 72 Polymorphism in Urologic Cancers
por: Wu, Wen‐Jeng, et al.
Publicado: (1995)

Arg72Pro Polymorphism of TP53 Gene and the Risk of Skin Cancer: a Meta-Analysis
por: Ye, Jun, et al.
Publicado: (2013)

Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer
por: Lin, Ying-Mei, et al.
Publicado: (2018)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy
por: Godai, Ten-i, et al.
Publicado: (2009)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
por: YONEDA, TOMOKO, et al.
Publicado: (2013)

TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals
por: Kodal, Jakob B., et al.
Publicado: (2017)

TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease
por: Li, Quanyi, et al.
Publicado: (2004)

Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan
por: Nikbakht Dastjerdi, Mehdi, et al.
Publicado: (2013)

The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism
por: Ramos-Araque, Maria E., et al.
Publicado: (2018)

Jane Skok: Choreography of allelic exclusion
por: Bashyam, Hema
Publicado: (2008)

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer
por: Costa, Sandra, et al.
Publicado: (2008)

No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects
por: Zhang, Anqi, et al.
Publicado: (2017)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

Somatic TP53 variants frequently confound germline testing results
por: Weitzel, Jeffrey N., et al.
Publicado: (2017)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
por: Zhao, Davidson, et al.
Publicado: (2022)

TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma
por: Rebbani, Khadija, et al.
Publicado: (2015)

Frequent Allelic Imbalance on Chromosome 18q21 in Early Superficial Colorectal Cancers
por: Akiyama, Yoshimitsu, et al.
Publicado: (1999)

A Case-Control Study of TP53 R72P Polymorphism in the Breast Cancer Patients of Ethnic Kashmiri Population
por: Syeed, Nidda, et al.
Publicado: (2010)

Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis
por: Han, Pei-Zhen, et al.
Publicado: (2019)

TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status
por: Zhang, Lei, et al.
Publicado: (2018)

The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies
por: Tian, Xin, et al.
Publicado: (2016)

TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients
por: Nairuz, Tahsin, et al.
Publicado: (2020)

Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women
por: Mostaid, Md Shaki, et al.
Publicado: (2021)

TP53 allele loss, mutations and expression in malignant melanoma.
por: Flørenes, V. A., et al.
Publicado: (1994)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
por: Burack, W. Richard, et al.
Publicado: (2023)

Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts
por: Haque, Mohammed Moquitul, et al.
Publicado: (2018)

Control de calidad en los laboratorios clínicos
por: Dharan, Murali

TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells
por: Altilia, Serena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ucbslic4135iorq8bpj1i5t3u8